Tested, Trusted, Approved: USANA CellSentials Earns ConsumerLab.com Seal of Approval for Purity and Potency Accessibility StatementSkip Navigation SALT LAKE CITY, March 24, 2026 /PRNewswire/ -- USANA (NYSE: USNA), a global leader in cellular nutrition, today announced that its flagship CellSentials supplement has earned the prestigious ConsumerLab.com Seal of Approval. This highly respected third-party certification is awarded only to products that meet rigorous standards for purity, potency, and label accu ...

Regulatory and Compliance Risks - Direct selling is subject to intense government scrutiny, and changes in laws or regulations could adversely affect the company's business [177]. - The company is subject to various governmental export control and trade sanctions laws that could impair its ability to compete in international markets [171]. - The company is subject to extensive government regulation regarding its products and manufacturing activities, which could limit or prevent sales in some markets [171]. - The company has faced legal actions and regulatory scrutiny regarding misleading product claims and earnings representations, which could lead to significant fines and operational changes [178]. - The company has faced regulatory challenges in various markets, including China, India, South Korea, Malaysia, and Indonesia, requiring modifications to its Compensation Plan to comply with local laws [190]. - The Chinese government has imposed significant fines on companies violating direct selling regulations, which could adversely affect the company's operations in China [201]. - The company must obtain direct selling licenses from municipalities and provinces in China to expand its business, with the application review process currently suspended since 2019 [203]. - The company’s operations in China are subject to evolving government regulations, which could materially harm its business if compliance is not maintained [194]. - Compliance with environmental laws and regulations may require substantial expenditures, potentially affecting financial condition and operations [221]. - Compliance with anti-corruption laws, including the U.S. Foreign Corrupt Practices Act, is critical as the company expands internationally, with potential severe penalties for violations [234][236]. Financial Performance and Market Conditions - The Greater China region accounts for a significant part of the company's business and expected growth, and a decline in sales or customers in this region would harm its financial condition [171]. - Economic conditions have negatively impacted sales and profitability, with ongoing uncertainty regarding future market conditions [274]. - The effective tax rate has significantly increased over the past few years and is expected to remain elevated due to a geographic misalignment between 76% of net sales generated outside the U.S. and the majority of operating expenses incurred in the U.S. [239]. - The effective tax rate may continue to exceed historical levels if the company cannot diversify income geographically or implement compliant cross-border tax planning strategies [241]. - The company is exposed to foreign currency risks due to a significant portion of sales generated outside the United States, which can affect sales and earnings [381]. Operational Challenges - The company may incur obligations relating to the activities of its Brand Partners, including potential reclassification of independent contractors to employees, which could impose additional financial responsibilities [186]. - The company has experienced adverse publicity related to enforcement of Brand Partner policies, making it difficult to attract and retain Brand Partners and Preferred Customers [185]. - The company has experienced temporary shortages of raw materials, leading to higher prices that negatively impacted gross margins [225]. - Delays and disruptions in transportation and distribution have resulted in increased costs and could negatively impact profitability [226]. - The company may face challenges in integrating acquired businesses, which could lead to unexpected costs and operational disruptions [266]. Strategic Initiatives and Acquisitions - The Hiya Acquisition may not be accretive to earnings per share and could result in additional costs and expenses, negatively affecting the market price of the company's common stock [176]. - The Hiya Acquisition was completed in December 2024, with integration activities expected to continue into 2025, potentially disrupting ongoing business [264]. - The company anticipates synergies from the Hiya Acquisition, but integration challenges may delay or prevent realization of these benefits [263]. - In 2023, the company launched an Affiliate program in certain markets, modifying its Brand Partner Compensation Plan to enhance earning opportunities [189]. Market Competition and Customer Dynamics - The company faces intense competition in the nutritional supplement market, with the need to adopt AI technology to maintain its competitive position [278]. - The company relies on Brand Partners and Preferred Customers for sales growth, with a noted decline in active Customers in several markets, including China [256]. - Rise's business is heavily dependent on a limited number of key retail customers, and any loss or reduction in orders could materially affect its financial condition [271]. - Adverse publicity and negative public perception regarding direct selling and product efficacy could harm the company's reputation and financial results [275]. Risk Management and Security - The company faces risks related to data security and privacy, including potential breaches that could lead to significant liabilities and damage to reputation [248][249]. - The company has implemented a business continuity and disaster recovery plan to mitigate risks associated with information technology systems, but vulnerabilities remain [247]. - The company has incurred substantial costs to comply with various data privacy and security laws, which may limit its ability to provide valuable products and services [255]. - The company is encountering an expanded risk landscape due to the use of artificial intelligence technologies, which may impact data security and compliance with evolving regulations [251]. Manufacturing and Supply Chain - Approximately 56% of the products sold to customers are manufactured in-house, with an increased focus on self-manufacturing of foods, personal care, and skincare products [220]. - 44% of product sales for the year ended January 3, 2026, were from third-party suppliers and manufacturers [222]. - Inflationary pressures and rising costs of commodities and raw materials could adversely affect profitability, as the company may not be able to pass all costs onto customers [216]. - The company has implemented strategies to mitigate currency fluctuation risks, including timely repatriation of earnings and entering into currency exchange contracts [215][382]. Ownership and Governance - Gull Global, Ltd., owned by founder Dr. Myron Wentz, held approximately 40.0% of the outstanding common stock as of January 3, 2026, giving him significant influence over company affairs [283]. - The concentration of stock ownership may delay or deter beneficial changes in control, potentially impacting shareholder interests [283]. - The company’s ability to protect its intellectual property is limited, as most products are not patent-protected, relying instead on trade secret laws [280].

Core Viewpoint - USANA Health Sciences (USNA) is experiencing significant selling pressure, with a 16.8% decline over the past four weeks, but is now positioned for a potential trend reversal as it enters oversold territory, supported by analyst expectations of better earnings than previously predicted [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is utilized to identify oversold conditions, with a reading below 30 indicating a stock may be oversold [2]. - USNA's current RSI reading is 29.62, suggesting that the heavy selling may be exhausting, indicating a possible bounce back towards equilibrium in supply and demand [5]. - RSI helps investors identify potential entry points for stocks that have fallen below their fair value due to unwarranted selling pressure [3]. Group 2: Fundamental Indicators - There is a strong consensus among sell-side analysts that USNA's earnings estimates for the current year have increased by 2.6% over the last 30 days, which typically correlates with price appreciation in the near term [7]. - USNA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [8].

Core Viewpoint - USANA Health Sciences (USNA) has shown a downtrend recently, losing 9.1% over the past week, but a hammer chart pattern suggests a potential trend reversal as buying interest may be emerging [1][2]. Technical Analysis - The hammer chart pattern indicates a potential bottoming out, suggesting that selling pressure may be exhausting, which could lead to a trend reversal [2][5]. - A hammer pattern forms when there is a small candle body with a long lower wick, indicating that despite a downtrend, buyers are starting to emerge [4][5]. - The effectiveness of the hammer pattern is enhanced when used alongside other bullish indicators, as its strength depends on its placement on the chart [6]. Fundamental Analysis - Recent upward revisions in earnings estimates for USNA serve as a bullish indicator, correlating strongly with near-term stock price movements [7]. - Over the last 30 days, the consensus EPS estimate for USNA has increased by 2.6%, indicating analysts expect better earnings than previously predicted [8]. - USNA holds a Zacks Rank of 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks, which typically outperform the market [9][10].

Core Insights - USANA Health Sciences is undergoing a significant turnaround as its main business segment, multi-level marketing (MLM), faces potential permanent decline [1] - The overall MLM industry is struggling, prompting USANA to pivot its business strategy [1] Company Overview - USANA's primary business model is based on MLM, which is currently experiencing challenges [1] - The company is adapting to the changing market conditions similar to other MLMs [1]

Core Viewpoint - USANA Health Sciences celebrates the achievement of 190 sponsored athletes who earned a record 28 medals at the 2026 Winter Olympic Games, showcasing the company's commitment to supporting elite athletes across various sports [1] Group 1: Athlete Performance - A total of 190 USANA-sponsored athletes participated in the 2026 Winter Olympic Games, representing eight national teams from four countries and competing in 12 winter sports [1] - US Ski & Snowboard led the medal count for USANA-partnered organizations with 17 medals [1] - Notable athletes included Alex Ferreira, who won a gold medal in men's freeski halfpipe, and other athletes from various disciplines such as bobsled, biathlon, ice hockey, speed skating, and snowboarding [1] Group 2: Organizational Support - USANA supported several national sporting organizations during the Games, including US Ski & Snowboard, US Speedskating, and Biathlon Canada, among others [1] - The partnership with US Speedskating, which began in 1999, continued at the 2026 Winter Games, contributing to five medals, including an Olympic record in the men's 1000m [1] Group 3: Company Commitment - Brent Neidig, USANA's chief commercial officer, highlighted the achievement of 28 medals as the company's most successful Winter Games performance, surpassing all countries except the United States, Italy, and Norway [1] - USANA's manufacturing facility in Salt Lake City is certified under NSF/ANSI dietary supplement Good Manufacturing Practice (GMP) requirements, ensuring high standards for elite athletes [1] - The company has been providing premium-quality nutrition and lifestyle products for over 30 years, emphasizing its commitment to empowering individuals to live healthier lives [1]

Core Insights - USANA Health Sciences, Inc. will participate in the Sidoti Small-Cap Virtual Conference on March 18-19, 2026, featuring a fireside chat and one-on-one meetings [1] - The company will also attend the 38th Annual ROTH Conference on March 23, 2026, located in Dana Point, CA, which will include one-on-one meetings [1] - A live webcast of the fireside chat at the Sidoti Small-Cap Virtual Conference will be available in the 'News/Events' section of the company's website [1]

Core Insights - USANA Health Sciences emphasizes the importance of disciplined reading as a leadership tool during National Reading Month, highlighting its benefits for executives in navigating market pressures and change [1] Company Overview - USANA Health Sciences, a billion-dollar global nutritional company based in Salt Lake City, focuses on health and wellness products and has been operational since 1992 [1] Leadership Philosophy - Kevin Guest, Chairman & CEO, advocates for reading as essential training for executives, enhancing mental discipline, analytical ability, and decision-making skills [1] - Guest's book, "All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony," reflects on the importance of core values and their integration into leadership practices [1] Competitive Advantage through Reading - Guest outlines five ways reading serves as a competitive advantage: 1. Innovation through cross-pollination: Exposure to diverse fields sparks new solutions [1] 2. Stronger communication: Regular readers articulate vision with precision [1] 3. Cognitive resilience: Reading enhances focus and composure in high-stakes situations [1] 4. Sharper decision-making: Engaging with complex arguments improves clarity [1] 5. Strategic foresight: Diverse ideas help leaders anticipate market shifts [1] Social Responsibility - Proceeds from Guest's book sales benefit the USANA Foundation, providing meals to hungry children, with over 112 million meals provided to date [1]

Core Insights - Rise Wellness has launched Protein Pop Plus, a new carbonated protein beverage with 30 grams of protein per 12-ounce can, now available at all 607 Costco locations in the U.S. [1][1][1] - Protein Pop Plus is designed to offer a refreshing alternative to traditional protein shakes, featuring zero sugar, no artificial sweeteners, and no caffeine [1][1][1] Product Details - Protein Pop Plus comes in three flavors: Citrus, Mango Peach, and Orange Cream, and is sweetened with a premium stevia leaf extract blend [1][1][1] - The beverage combines whey protein isolate and bovine collagen, providing a clear, lightly carbonated drink that appeals to consumers seeking functional nutrition [1][1][1] Market Positioning - The launch follows the success of the original Protein Pop, which debuted at Natural Products Expo West and was later launched in Target stores with 22 grams of protein [1][1][1] - Protein Pop Plus aims to differentiate itself in the functional beverage market by offering a carbonated experience, making it suitable for consumption throughout the day [1][1][1] Company Background - Protein Pop is one of two brands owned by Rise Wellness, a subsidiary of USANA Health Sciences, which develops premium nutritional supplements and functional foods [1][1][1] - USANA Health Sciences holds a 78.8% controlling stake in Hiya Health Products and owns 100% of Rise Wellness, emphasizing a commitment to health and wellness [1][1][1]

Core Viewpoint - The comparison between USANA Health Sciences (USNA) and United Therapeutics (UTHR) indicates that USNA is currently more attractive to value investors due to its stronger Zacks Rank and favorable valuation metrics [1][3]. Group 1: Zacks Rank and Earnings Estimates - USNA has a Zacks Rank of 1 (Strong Buy), while UTHR has a Zacks Rank of 4 (Sell), suggesting a more favorable earnings outlook for USNA [3]. - The Zacks Rank system emphasizes companies with positive earnings estimate revisions, indicating that USNA is likely experiencing an improvement in its earnings outlook [3]. Group 2: Valuation Metrics - USNA has a forward P/E ratio of 10.84, significantly lower than UTHR's forward P/E of 16.93, indicating that USNA may be undervalued [5]. - The PEG ratio for USNA is 0.90, while UTHR's PEG ratio is 2.52, further suggesting that USNA is more attractive based on expected earnings growth [5]. - USNA's P/B ratio is 0.74, compared to UTHR's P/B of 3.09, reinforcing the notion that USNA is undervalued relative to its book value [6]. - These metrics contribute to USNA's Value grade of A and UTHR's Value grade of C, highlighting USNA's superior valuation profile [6].